Form 4 Filing for Arcturus Therapeutics Holdings Inc.

This filing details stock option grants and holdings for Joseph Roberts, Controller at Arcturus Therapeutics Holdings Inc. The report includes information on 9 stock option grants with exercise prices ranging from $8.00 to $99.29 and expiration dates between 2028 and 2034. The options are for the purchase of a total of 45,808 shares of Common Stock. Additionally, Joseph Roberts directly owns 2,001 shares of Common Stock and indirectly owns 200 shares of Common Stock through his spouse. The filing is dated December 19, 2025, reporting on transactions up to December 12, 2025.